Funded Tech Companies
Exeliom Biosciences
Wondering who invested in Exeliom Biosciences? Capital Grand Est, Auriga Partners and UI Investissement joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Exeliom Biosciences
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
67 Rue Des Godrans
Dijon, 21000
FR
Dijon, 21000
FR
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
We develop novel therapies that modulate the immune-system in a non-suppressive manner. The fact that our drug candidates modulate, but do not suppress, the immune-system is what makes them more suited for chronic administration than currently available medicines, especially for the majority of patients who have mild to moderate symptoms. We source our drug candidates by studying and analyzing real-life observational human clinical trial data, in a non-systematic manner and without a priori. This pioneering translational human discovery first approach is what makes us and our programs so special.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/20/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Benjamin Hadida
Co-Founder
Patrick Gervais
Co-Founder
Philippe Langella
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs